BINEX Co. Ltd (KQ:053030) — Market Cap & Net Worth
Market Cap & Net Worth: BINEX Co. Ltd (053030)
BINEX Co. Ltd (KQ:053030) has a market capitalization of $170.14 Million (₩251.06 Billion) as of June 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17293 globally and #700 in its home market, demonstrating a 7.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BINEX Co. Ltd's stock price ₩8050.00 by its total outstanding shares 31187800 (31.19 Million). Review how much debt does BINEX Co. Ltd carry to assess the company's total debt and financial obligations.
BINEX Co. Ltd Market Cap History: 2015 to 2026
BINEX Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $342.40 Million to $170.14 Million (-6.51% CAGR).
Index Memberships
BINEX Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$273.60 Billion | 0.06% | #265 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$273.60 Billion | 0.06% | #265 of 1384 |
Weight: BINEX Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BINEX Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BINEX Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
BINEX Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $342.40 Million | $66.54 Billion | -$9.29 Billion | 0.01x | N/A |
| 2016 | $358.25 Million | $80.92 Billion | -$3.00 Billion | 0.00x | N/A |
| 2017 | $228.26 Million | $78.03 Billion | -$11.29 Billion | 0.00x | N/A |
| 2018 | $193.60 Million | $104.04 Billion | $6.34 Billion | 0.00x | 0.03x |
| 2019 | $166.97 Million | $125.26 Billion | $8.50 Billion | 0.00x | 0.02x |
| 2020 | $561.15 Million | $132.98 Billion | $6.41 Billion | 0.00x | 0.09x |
| 2021 | $321.26 Million | $134.40 Billion | $19.09 Billion | 0.00x | 0.02x |
| 2022 | $244.12 Million | $156.68 Billion | $12.44 Billion | 0.00x | 0.02x |
| 2023 | $189.16 Million | $154.82 Billion | $4.67 Billion | 0.00x | 0.04x |
| 2024 | $387.63 Million | $130.05 Billion | -$35.07 Billion | 0.00x | N/A |
Competitor Companies of 053030 by Market Capitalization
Companies near BINEX Co. Ltd in the global market cap rankings as of June 18, 2026.
Key companies related to BINEX Co. Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #4310 globally with a market cap of $3.84 Billion USD ( ₩5.67 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7206 globally with a market cap of $1.57 Billion USD ( ₩2.32 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #8689 globally with a market cap of $1.10 Billion USD ( ₩1.62 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10478 globally with a market cap of $739.87 Million USD ( ₩1.09 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #4310 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.84 Billion | ₩265000.00 |
| #7206 | ST Pharm Co.Ltd | KQ:237690 | $1.57 Billion | ₩124100.00 |
| #8689 | NatureCell Co.Ltd | KQ:007390 | $1.10 Billion | ₩30550.00 |
| #10478 | Oscotec Inc | KQ:039200 | $739.87 Million | ₩38850.00 |
BINEX Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, BINEX Co. Ltd's market cap moved from $342.40 Million to $ 170.14 Million, with a yearly change of -6.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩170.14 Million | -46.26% |
| 2025 | ₩316.61 Million | -18.32% |
| 2024 | ₩387.63 Million | +104.92% |
| 2023 | ₩189.16 Million | -22.51% |
| 2022 | ₩244.12 Million | -24.01% |
| 2021 | ₩321.26 Million | -42.75% |
| 2020 | ₩561.15 Million | +236.08% |
| 2019 | ₩166.97 Million | -13.76% |
| 2018 | ₩193.60 Million | -15.19% |
| 2017 | ₩228.26 Million | -36.28% |
| 2016 | ₩358.25 Million | +4.63% |
| 2015 | ₩342.40 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of BINEX Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $170.14 Million USD |
| MoneyControl | $170.14 Million USD |
| MarketWatch | $170.14 Million USD |
| marketcap.company | $170.14 Million USD |
| Reuters | $170.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BINEX Co. Ltd
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; … Read more